Systemic sclerosis (scleroderma) trials in Türkiye

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Where

  Fatih-Istanbul, Ümraniye

  Age

  5 years to 80 years

  People

  1,072 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07691970
• No phaseTaking people
  EFESO: Study on Juvenile Onset Eosinophilic Fasciitis

  Where

  Istanbul

  Age

  Up to 18 years

  People

  20 worldwide

  Run by

  Meyer Children's Hospital IRCCS

  See details and how to joinNCT07348263